Zobrazeno 1 - 10
of 32
pro vyhledávání: '"P. E. Beales"'
Autor:
P. E. Beales, Paolo Pozzilli
Publikováno v:
Diabetes/Metabolism Research and Reviews. 18:114-117
Background Thiazolidinediones (TZDs) are a recently introduced generation of drugs acting as receptor agonists to reduce insulin resistance and used currently in combination with other hypoglycaemic agents for the treatment of type 2 diabetes. In add
Publikováno v:
Autoimmunity. 35:329-333
The non-obese diabetic (NOD) mouse is a model of spontaneous type-1 diabetes used in the field of diabetes research. This study looked at the adrenal glands of NOD and control mice both indirectly in vivo for hormone secretion, and directly in vitro
Publikováno v:
Autoimmunity. 32:109-113
In vitro cell mediated reactivity to Glutamic Acid Decarboxylase (GAD) has been reported in man and in the non-obese diabetic (NOD) mouse. The demonstration of such reactivity in vivo using GAD in a simple intradermal skin test would be useful for ma
Publikováno v:
Diabetes/Metabolism Research and Reviews. 15:21-28
Background The non-obese diabetic (NOD) mouse is a widely used model of Type 1 diabetes mellitus (Type 1 DM), which displays many of the characteristics of the disease found in humans. Nicotinamide (NA) is currently being tested in large-scale, multi
Autor:
Paolo Pozzilli, P. E. Beales, Roberto Liddi, Kenneth Batchelor, Alberto Signore, E. Procaccini, A. Giorgini
Publikováno v:
European Journal of Pharmacology. 357:221-225
Troglitazone has recently been introduced in the treatment of Type 2 diabetes. In addition to its anti-diabetic effects it acts as a perixosome proliferator activated receptor-gamma (PPAR-gamma) agonist and has anti-inflammatory properties by inhibit
Autor:
P. E. Beales, Alberto Signore, E. Procaccini, Giovina Ruberti, Roberto Testi, A. Annovazzi, J. Spencer
Publikováno v:
Diabetologia. 40:1476-1479
The non-obese diabetic (NOD) mouse is widely used to study the pathogenesis of insulin-dependent diabetes mellitus. However, the mechanisms responsible for beta-cell destruction, in this model, are still poorly defined. The CD95/CD95L system among ot
Autor:
A. Giorgini, Paolo Pozzilli, P. E. Beales, Maria Cristina Albertini, A. J. K. Williams, Mohammed I. Hawa
Publikováno v:
Acta Diabetologica. 32:53-56
Glutamic acid decarboxylase (GAD) is the enzyme responsible for the synthesis of gamma-aminobutyric acid (GABA). GAD has been identified as a 64-kDa antigen expressed in pancreatic beta-cells, to which autoantibodies are generated prior to the onset
Autor:
Pietro Cugini, Alberto Signore, P. E. Beales, A. J. K. Williams, Elisabetta Ferretti, A. M. Toscano, E. Procaccini, Paolo Pozzilli
Publikováno v:
Histochemistry. 101:263-269
Non-obese diabetic (NOD) mice spontaneously develop an autoimmune diabetes with higher incidence in females than in males. In order to elucidate possible factors involved in the different incidence of diabetes between male and female mice, we studied
Publikováno v:
Diabetes Research and Clinical Practice. 21:5-9
It has been suggested that heparin and its analogues may have a suppressive effect on the immune response by interfering with T-lymphocyte heparinase activity, thus altering the ability of T-lymphocytes to penetrate the extracellular matrix and migra
Autor:
E. Procaccini, Alberto Signore, E. A. M. Gale, J. Krug, Paolo Pozzilli, P. E. Beales, A. J. K. Williams, S. Xu
Publikováno v:
Diabetologia. 36:487-492
The functional state of beta cells may influence the rate of their destruction in Type 1 (insulin-dependent) diabetes mellitus. We examined the effect of diazoxide, which inhibits insulin secretion, or tolbutamide, which stimulates insulin secretion,